Real‐World Impact of Amiodarone on Apixaban Population Pharmacokinetics in Hospitalized Patients
Sign Up to like & getrecommendations! Published in 2025 at "Clinical and Translational Science"
DOI: 10.1111/cts.70392
Abstract: Despite common coadministration in nonvalvular atrial fibrillation (NVAF), there is minimal evidence regarding the impact of concomitant amiodarone use on apixaban pharmacokinetics (PK). We described the population PK of apixaban (2.5 and 5 mg twice daily)… read more here.
Keywords: hospitalized patients; real world; world impact; concomitant amiodarone ... See more keywords